Monofocal motor neuropathy: Improvement with intravenous immunoglobulin
- 28 March 2002
- journal article
- case report
- Published by Wiley in Muscle & Nerve
- Vol. 25 (5) , 674-678
- https://doi.org/10.1002/mus.10088
Abstract
Multifocal motor neuropathy (MMN) is a chronic, immune‐mediate, peripheral myelinopathy. Inherent in its name, MMN implies involvement of two or more motor nerves. We report three patients with weakness and partial motor conduction block restricted to a single nerve and localized to sites that are not at risk for entrapment or compression injury. None of the patients had sensory involvement and all showed a favorable response to intravenous immunoglobulin therapy. Based on these observations and reports of three additional patients, we believe that monofocal motor neuropathy is a partial form of MMN and should be treated as such. © 2002 Wiley Periodicals, Inc. Muscle Nerve 25: 000–000, 2002Keywords
This publication has 8 references indexed in Scilit:
- 79th ENMC International Workshop: Multifocal motor neuropathyNeuromuscular Disorders, 2001
- Multifocal Motor NeuropathyPublished by Oxford University Press (OUP) ,2001
- Intravenous immunoglobulin therapy in multifocal motor neuropathy: A double-blind, placebo-controlled studyBrain, 2001
- Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatmentAnnals of Neurology, 2000
- Letter to the editorMuscle & Nerve, 2000
- Electrophysiologic findings in multifocal motor neuropathyNeurology, 1997
- Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- A treatable multifocal motor neuropathy with antibodies to GM1 gangliosideAnnals of Neurology, 1988